AddOn Cyramza Flops in FirstLine Gastric Cancer Trial

Add-On Cyramza Flops in First-Line Gastric Cancer Trial

(MedPage Today) -- No improvement in progression-free or overall survival

Original Article: Add-On Cyramza Flops in First-Line Gastric Cancer Trial

More From BioPortfolio on "Add-On Cyramza Flops in First-Line Gastric Cancer Trial"